The DNA Sequencing Industry has rapidly transformed into one of the most crucial areas of biotechnology. What was once a time ...

Allworth Financial LP lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 55.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 6,647 shares of the ...

Estrella Immunopharma, Inc. ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune ...

Consolidated Communications Holdings, LLC (the "Company" or "Consolidated") today announced that it will periodically make available certain information for current and prospective bondholders and ...

Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The ...

Molecular Spectroscopy Market Valued at $7.15 Billion in 2023 and projected to grow at a 7.15% CAGR, driven by technological innovation and ...

The global Immunohistochemistry Market is valued at an estimated USD 3.4 billion in 2024 and is projected to reach USD 5.2 ...

After growing up in Spokane, Schlenske lived in the Bay Area and the Midwest before returning to the Pacific Northwest with ...

Agilent Technologies, Inc. (NYSE:A), a leading provider of analytical instruments and services for laboratories worldwide, ...

Headlines,Savant Capital LLC expanded its share count by a modest percentage during the final quarter.,Several capital management entities adjusted their share quantities in the medical research firm.